NLS Pharmaceutics announced that the FDA has accepted its investigational new drug application (IND) for Quilience, the company‘s drug candidate for the treatment of narcolepsy.
FT218 exhibited a pharmacokinetic profile that supported once-nightly dosing with adequate concentrations maintained throughout the night.Read More
Sunosi is a dual-acting dopamine and norepinephrine reuptake inhibitor for the treatment of persistent daytime sleepiness in adults.Read More
Responsibilities include leading the US commercial launch of the company’s lead program, once-nightly FT218, pending regulatory approval.Read More
Researchers ID Neurons in Mouse Brainstem that Suppress Movement During REM Sleep. It Could Be a Treatment Target for RBD, Narcolepsy, & Cataplexy.
When the researchers blocked the input to these neurons, the mice began moving during their sleep, just like someone with RBD.Read More
NeurologyAdvisor: A study in the Journal of Clinical Medicine sought to investigate high cognitive functioning in children with narcolepsy, and whether it was a protective factor for school and behavioral difficulties in this population.Read More
A literature review from Stanford University looks at how the popular narcolepsy medication sodium oxybate impacts heart health.Read More
The FDA says that Harmony Biosciences’ drug—previously approved for excessive daytime sleepiness in narcolepsy—works for cataplexy too. Harmony’s chief medical officer explains how this impacts healthcare practitioners and patients.Read More
Narcolepsy Market Assessment: Once-Nightly Sodium Oxybate May Appeal to More Patients Than Just Those on Twice-Nightly Dosing
“Six out of 10 sodium oxybate-eligible patients are not going on therapy today, with twice-nightly dosing being the primary reason cited.”Read More
The impact of the coronavirus pandemic on people’s daily lives has resulted in altered sleep patterns and an increase in narcolepsy symptoms.Read More
Harmony Biosciences Gives $74,000 to Organizations Supporting People with Narcolepsy During COVID-19
The grant program awarded $65,000 to four organizations in 2019, a figure which this year rose to $74,000 awarded to three organizations.Read More
The settlement could pave the way for resolution of 80 cases over Pandemrix vaccine, reports The Irish Times.Read More